xeneticbio.com (XBIO) - Cash Funds Calculated per Share

Corporate emblem and logo of Xenetic Biosciences, Inc. (XBIO)

Growth for Xenetic Biosciences (XBIO) is driven by the success of its DNase platform in tumor therapy and partnerships with pharmaceutical behemoths. The technical equipment of the production facilities is currently scaling protein output. Quarterly cash per share dynamics demonstrate the company's defensive barrier, where the indicator level stands at 2.47. The developer's high scientific authority in immunology confirms the effectiveness of its innovative drug delivery.

Cash per Single Share: xeneticbio.com (XBIO) for 07/04/2022 - 11/21/2026

Comprehensive metric breakdowns and analytics for Xenetic Biosciences, Inc. (XBIO)

- share price and consensus valuation forecast:
- cash position and cash flow details:
Comprehensive company analysis:XBIO (Xenetic Biosciences Inc.)
Brand item of xeneticbio.com

For the biotech sector, liquidity is a key survival factor for Xenetic Biosciences (XBIO) during the development of tumor therapies. This metric is calculated by dividing total cash reserves by the number of shares outstanding. By analyzing the cash per share chart, an investor determines the intrinsic value of their holding. A steady stream of royalties from partners offsets the costs of early-stage trials, confirming the business's financial stability.

Analysis of competing companies

Cash Funds per Single Share ONC (BeiGene Corp)|Cash per Single Share HALO (Halozyme Therapeutics, Inc.)|Cash per Share Revolution Medicines, Inc. (RVMD)|Cash per Share AAPG (ascentage.com)|CG Oncology Inc (CGON) - Cash on Hand per Share|URGN - Cash Funds per Share|Bicara Bio - Cash Calculated per Single Share|PSNL: Cash per Share|Cash Funds per Single Share ERAS|Cash per Single Share DCTH|Cash on Hand per Share Y-mAbs Therapeutics Inc YMAB|Cash per Share AURA|CADL (Candel Therapeutics, Inc.) - Amount of Cash per Share|Cash Funds per Share Accuray Inc ARAY|Cash Funds Calculated per Share SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Cash per Share|Cash on Hand per Share Citius Oncology|HURA: Cash per Share|Cash Money per Share TARA (Protara)|FATE (fatetherapeutics.com) - Cash per Share|Cash on Hand per Share Aadi Bioscience WHWK|Cash per Share TCRX|CSBR - Cash on Hand per Share|XBiotech - Cash per Single Share|CEL-SCI Corporation (CVM) - Cash on Hand per Share|OSTX - Cash Funds per Share|Cash on Hand per Share Radiopharm Theranostics Ltd|ARTV (artivabio.com) - Cash per Single Share|ANL (Adlai Nortye Ltd) - Cash Funds per Share|Cash per Single Share VERU|Tempest Therapeutics (TPST) - Cash Funds Calculated per Share|Cash per Share XLO|Cash per Single Share Renovaro RENB|Cash per Share MURA (Mural Oncology PLC)|KAPA - Cash per Single Share|OnKure Therapeutics - Cash per Share|w2.cytomed.sg - Cash Calculated per Single Share|Curis Corp (CRIS) - Cash Funds per Share|Cash on Hand per Share Apollomics Corp (APLM)|Cash Funds per Share Tharimmune|Cash per Share advanbiomed.com|Cash Funds per Share Genprex, Inc (GNPX)|Cash Funds Calculated per Share Calidi Biotherapeutics, Inc.|Cash per Share SBFM (Sunshine Biopharma Inc.)|Amount of Cash per Share SLRX|PPBT - Cash Funds per Share|AONC (aoncology.com) - Cash Funds per Single Share|BGNE: Cash per Share|Checkpoint Therapeutics Inc (CKPT) - Cash per Share|ELEV (Elevation Oncology Inc.) - Cash per Share|icadmed.com (ICAD) - Cash Funds Calculated per Share|Cash per Share IKNA|NTBL (Notable Labs) - Amount of Cash per Share|Cash per Share VIRX (Viracta Therapeutics)|Cash Funds Calculated per Share MorphoSys AG (MOR)|NAYA Biosciences Corp - Cash per Share|Cash on Hand per Share ascentage.com